JP2022151814A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2022151814A5 JP2022151814A5 JP2022047297A JP2022047297A JP2022151814A5 JP 2022151814 A5 JP2022151814 A5 JP 2022151814A5 JP 2022047297 A JP2022047297 A JP 2022047297A JP 2022047297 A JP2022047297 A JP 2022047297A JP 2022151814 A5 JP2022151814 A5 JP 2022151814A5
- Authority
- JP
- Japan
- Prior art keywords
- concentration
- polysorbate
- pharmaceutical composition
- buffer
- poloxamer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021049485 | 2021-03-24 | ||
| JP2021049485 | 2021-03-24 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022151814A JP2022151814A (ja) | 2022-10-07 |
| JP2022151814A5 true JP2022151814A5 (https=) | 2025-04-01 |
Family
ID=83395731
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022047297A Pending JP2022151814A (ja) | 2021-03-24 | 2022-03-23 | 安定な水性医薬組成物又は凍結乾燥医薬組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240165258A1 (https=) |
| EP (1) | EP4311555A4 (https=) |
| JP (1) | JP2022151814A (https=) |
| KR (1) | KR20230160848A (https=) |
| CN (1) | CN116997352A (https=) |
| AU (1) | AU2022245592B2 (https=) |
| BR (1) | BR112023019201A2 (https=) |
| CA (1) | CA3214463A1 (https=) |
| MX (1) | MX2023011087A (https=) |
| WO (1) | WO2022202947A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240269244A1 (en) * | 2021-05-12 | 2024-08-15 | Jcr Pharmaceuticals Co., Ltd. | Pharmaceutical Composition for Treatment of Mucopolysaccharidosis Type 1 |
| AR133746A1 (es) * | 2023-09-14 | 2025-10-29 | Green Cross Corp | NUEVA FORMULACIÓN LIOFILIZADA QUE CONTIENE PROTEÍNA DE FUSIÓN a-GALACTOSIDASA A |
| KR20250081554A (ko) * | 2023-11-29 | 2025-06-05 | 주식회사 에스엔바이오사이언스 | 시롤리무스 및 알부민을 포함하는 나노입자, 이를 포함하는 피하투여용 약제학적 조성물 및 이의 제조방법 |
| WO2025229980A1 (ja) * | 2024-05-01 | 2025-11-06 | Ｊｃｒファーマ株式会社 | 凍結乾燥製剤 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3946246B2 (ja) * | 1993-02-02 | 2007-07-18 | ゾーマ・コーポレイション | 殺菌性／浸透性増大タンパク質（Ｂａｃｔｅｒｉｃｉｄａｌ／Ｐｅｒｍｅａｂｉｌｉｔｙ Ｉｎｃｒｅａｓｉｎｇ ｐｒｏｔｅｉｎ：ＢＰＩ）及び界面活性剤を含有する医薬組成物 |
| CN104887620A (zh) * | 2007-05-02 | 2015-09-09 | 诺沃—诺迪斯克保健股份有限公司 | 包括芳香族防腐剂和抗氧化剂的高浓度因子vii多肽制剂 |
| US9657310B2 (en) | 2012-04-27 | 2017-05-23 | Jcr Pharmaceuticals Co., Ltd. | Expression vector |
| AU2017386888B2 (en) * | 2016-12-28 | 2024-08-08 | Jcr Pharmaceuticals Co., Ltd. | Lyophilized preparation |
| JOP20190162A1 (ar) * | 2016-12-30 | 2019-06-27 | Biocad Joint Stock Co | تركيبة صيدلانية مائية من جسم مضاد لـ tnf? أحادي النسيلة معاود الارتباط الجيني |
| CN111278453A (zh) * | 2017-09-07 | 2020-06-12 | Jcr制药股份有限公司 | 水性药物组合物 |
| US20240269244A1 (en) * | 2021-05-12 | 2024-08-15 | Jcr Pharmaceuticals Co., Ltd. | Pharmaceutical Composition for Treatment of Mucopolysaccharidosis Type 1 |
-
2022
- 2022-03-23 US US18/283,050 patent/US20240165258A1/en active Pending
- 2022-03-23 BR BR112023019201A patent/BR112023019201A2/pt unknown
- 2022-03-23 AU AU2022245592A patent/AU2022245592B2/en active Active
- 2022-03-23 KR KR1020237035015A patent/KR20230160848A/ko active Pending
- 2022-03-23 CN CN202280022149.2A patent/CN116997352A/zh active Pending
- 2022-03-23 CA CA3214463A patent/CA3214463A1/en active Pending
- 2022-03-23 JP JP2022047297A patent/JP2022151814A/ja active Pending
- 2022-03-23 EP EP22775729.1A patent/EP4311555A4/en active Pending
- 2022-03-23 MX MX2023011087A patent/MX2023011087A/es unknown
- 2022-03-23 WO PCT/JP2022/013755 patent/WO2022202947A1/ja not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022151814A5 (https=) | ||
| KR102843708B1 (ko) | 이중특이적 항체 작제물을 포함하는 약제학적 조성물 | |
| TWI911431B (zh) | 抗rsv單株抗體配製物 | |
| JP2024099682A5 (https=) | ||
| JP2021512881A5 (https=) | ||
| JP5877161B2 (ja) | クロストリジウム・ディフィシル感染を予防または抑制するための治療法 | |
| US5932223A (en) | Rotavirus vaccine formulations | |
| US6403098B1 (en) | Rotavirus vaccine formulations | |
| US6616931B1 (en) | Rotavirus vaccine formulations | |
| JP2024099628A5 (https=) | ||
| US12251474B2 (en) | Process for lyophilized pharmaceutical formulations of a therapeutic protein | |
| JP2010511665A5 (https=) | ||
| JP7710485B2 (ja) | 抗Ｈｅｒ２抗体薬物コンジュゲートの製剤 | |
| JP2009524595A5 (https=) | ||
| TW201223541A (en) | Liquid formulations of long acting interferon alpha conjugate | |
| EP0939648B1 (en) | Rotavirus vaccine formulations | |
| JP2019509311A5 (https=) | ||
| JP2024540377A5 (https=) | ||
| IL276911B1 (en) | Variants of the carboxylation rate of antibodies | |
| TW201735940A (zh) | 長效人類生長激素共軛物之新穎液體調配物 | |
| JP2020506882A (ja) | 炎症性障害の治療療法 | |
| JP2024522855A5 (https=) | ||
| US20250152706A1 (en) | Compositions for oral delivery of biotherapeutics | |
| MX2007000421A (es) | Vehiculo para medicamentos para la obtencion de biodisponibilidad oral. | |
| JP2022176154A5 (https=) |